Eurofins-Cerep Logo

Eurofins-Cerep

Contract research organization for pre-clinical in vitro drug discovery services.

ALECR | PA

Overview

Corporate Details

ISIN(s):
FR0004042232 (+3 more)
LEI:
9695004C9D3ZX7FTZY16
Country:
France
Address:
2 RUE DU PROFESSEUR GARGOUIL, 86600 CELLE-LEVESCAULT

Description

Eurofins-Cerep is a Contract Research Organization (CRO) specializing in pre-clinical drug discovery services. The company provides solutions for in vitro drug profiling and screening in pharmacology, supporting pharmaceutical, biopharmaceutical, and biotechnology companies in the early stages of new drug development. Its services focus on delivering critical data regarding the biological activity and potential liabilities of chemical compounds, which aids clients in the identification and optimization of promising drug candidates before they proceed to clinical trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2019-04-29 00:00
rapport annuel 2018
French 5.2 MB
2018-05-02 08:57
Rapport financier annuel 2017
French 1.4 MB
2017-04-28 19:00
RAPPORT FINANCIER ANNUEL
French 1.6 MB
2017-01-27 18:20
Eurofins-Cerep annonce la fin de la période de regroupement d'actions
French 367.5 KB
2016-10-26 19:03
Rapport Financier Semestriel - 1er semestre 2016
French 506.8 KB
2016-04-29 21:30
RAPPORT FINANCIER ANNUEL
French 11.0 MB
2015-10-29 11:43
RAPPORT FINANCIER SEMESTRIEL - SEMESTRE CLOS LE 30 JUIN 2015
French 557.7 KB
2015-10-28 19:00
Eurofins-Cerep annonce ses résultats du 1er semestre 2015
French 237.1 KB
2015-05-27 13:29
RAPPORT ANNUEL 2014
French 1.5 MB
2015-01-14 15:00
Avis préalable à la mise en vente d'actions non réclamées
French 193.4 KB
2015-01-14 14:21
Avis de regroupement d'actions (BALO du 17 décembre 2014 - Bulletin n° 151)
French 120.4 KB
2014-04-30 16:15
Rapport Annuel 2013
French 2.2 MB
2010-03-29 15:00
2009 consolidated results / Positive EBITDA in the second half
English 169.7 KB
2010-03-26 19:00
Résultats consolidés 2009 : un EBE positif au second semestre
French 181.8 KB
2010-03-19 08:00
Introduction aujourd’hui de Cerep sur Alternext
French 110.1 KB

Automate Your Workflow. Get a real-time feed of all Eurofins-Cerep filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eurofins-Cerep

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eurofins-Cerep via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.